10 results
10-K
2023 FY
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
significant delays during the transition. This risk may be heightened by our use of single-source supplier arrangements. Furthermore, if a CMO or other third
10-K
2023 FY
EX-10.20
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
professional, as well as any other service provider, supplier and manufacturer. (c) Employees and Sources of Supply. The Executive agrees … , encourage or entice any vendor, supplier, manufacturer, franchisor or licensor to discontinue dealing with the Company Group, to terminate any franchise
10-K
2023 FY
EX-10.22
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
office, clinic or other healthcare professional, as well as any other service provider, supplier and manufacturer. (c) Employees and Sources of Supply … Group or such affiliate or (ii) attempt to induce, encourage or entice any vendor, supplier, manufacturer, franchisor or licensor to discontinue
10-K
2023 FY
EX-10.17
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
, investigator, physician’s office, clinic or other healthcare professional, as well as any other service provider, supplier and manufacturer. (c) Employees … Group or such affiliate or (ii) attempt to induce, encourage or entice any vendor, supplier, manufacturer, franchisor or licensor to discontinue
20-F
2020 FY
EX-4.4
ADCT
Adc Therapeutics SA
18 Mar 21
Annual report (foreign)
7:12am
law enforcement, regulatory or other Governmental Authority or any customer or supplier, or has admitted to, or been found by a court in any
F-1/A
EX-1.1
giwls
11 May 20
Registration statement (foreign) (amended)
6:26am
F-1
EX-10.3
vr3gqhevpn0kmwmro87
24 Apr 20
Registration statement (foreign)
5:23pm
DRS
EX-10.3
ko187y 7yxrcn
2 Mar 20
Draft registration statement
12:00am
F-1/A
EX-1.1
fdyfp
23 Sep 19
Registration statement (foreign) (amended)
6:08am
F-1
EX-10.3
jijd7k5qfs
6 Sep 19
Registration statement (foreign)
5:12pm
- Prev
- 1
- Next